ROS1 and non-small cell lung carcinoma: The first attempt to detect ROS1 rearrangements in the CTCs isolated by ISET technology of four NSCLC patients under crizotinib was undertaken by Pailler et al., who used a filter-adapted-fluorescence in situ hybridization (FA-FISH) protocol.